CAMBRIDGE NUTRITIONAL SCIENCES PLC — Director's Dealing 2021

Apr 19, 2021

National Storage Mechanism | Additional information

RNS Number : 8005V

Omega Diagnostics Group PLC

19 April 2021

19 April 2021

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Director/PDMR Shareholding

Omega Diagnostics (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance testing, announces that Derek Brady, Group Strategic Sourcing Director has sold in total 14,673 ordinary shares of 4 pence each in the capital of the Company ("Ordinary Shares"), at a price of 95 pence per share. Following the sale Mr. Brady holds no Ordinary Shares.

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.The below notification is made in accordance with the requirements of the EU Market Abuse Regulation.

Contacts: 

Omega Diagnostics Group PLC	Tel: 01259 763 030
Colin King, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
finnCap Ltd	Tel: 020 7220 0500
Geoff Nash / Teddy Whiley (Corporate Finance)
Alice Lane (ECM)
Walbrook PR Limited	Tel: 020 7933 8780 or [email protected]
Paul McManus	Mob: 07980 541 893
Lianne Cawthorne	Mob: 07584 391 303

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Derek Brady
2	Reason for notification
a.	Position/Status	PDMR (Group Strategic Sourcing Director)
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Omega Diagnostics Group Plc
b.	LEI	2138007U9P4BTZTYIR92
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Ordinary Shares of 4 pence each ISIN: GB00B1VCP282
b.	Nature of the transaction	Sale of Ordinary Shares
c.	Price(s) and volume(s)
	Price(s)	Volume(s)
	95p	14,673	Sale
d.	Aggregated information Aggregated Purchase Volume Aggregated Purchase Price Aggregated Sale Volume Aggregated Sale Price	As above.
e.	Date of the transaction	13 April 2021
f.	Place of the transaction	London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBRGDSSXBDGBL